0001140361-23-019677.txt : 20230421
0001140361-23-019677.hdr.sgml : 20230421
20230421202028
ACCESSION NUMBER: 0001140361-23-019677
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230419
FILED AS OF DATE: 20230421
DATE AS OF CHANGE: 20230421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MANUSO JAMES S J
CENTRAL INDEX KEY: 0001236365
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34079
FILM NUMBER: 23837708
MAIL ADDRESS:
STREET 1: 5130 ROUTE 212
CITY: WILLOW
STATE: NY
ZIP: 12495
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ocuphire Pharma, Inc.
CENTRAL INDEX KEY: 0001228627
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113516358
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 37000 GRAND RIVER AVE.
STREET 2: SUITE 120
CITY: FARMINGTON HILLS
STATE: MI
ZIP: 48335
BUSINESS PHONE: 248-681-9815
MAIL ADDRESS:
STREET 1: 37000 GRAND RIVER AVE.
STREET 2: SUITE 120
CITY: FARMINGTON HILLS
STATE: MI
ZIP: 48335
FORMER COMPANY:
FORMER CONFORMED NAME: REXAHN PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20050516
FORMER COMPANY:
FORMER CONFORMED NAME: CORPORATE ROAD SHOW DOT COM INC
DATE OF NAME CHANGE: 20030423
4
1
form4.xml
X0407
4
2023-04-19
0001228627
Ocuphire Pharma, Inc.
OCUP
0001236365
MANUSO JAMES S J
C/O OCUPHIRE PHARMA, INC.
37000 GRAND RIVER AVE, SUITE 120
FARMINGTON HILLS
MI
48335
true
false
Common Stock
2023-04-19
4
A
0
2819
A
57828
D
The Reporting Person was granted shares of common stock in lieu of incremental cash amounts for board services for 2023. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock for the 30 consecutive trading days ending on and including the last trading day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $4.27 per share, the average of the closing price of the common stock for the 30 consecutive trading days prior to April 19, 2023.
/s/ Emily J. Johns, by Power of Attorney
2023-04-21